छोड़कर सामग्री पर जाएँ

Aurobindo Pharma shares trade lower after US FDA slaps 10 observations

  • द्वारा
  • Latest News

The observations are procedural in nature and will be responded to within the stipulated time, while the plant is yet to start commercial operations, company said.

Read More

​ The observations are procedural in nature and will be responded to within the stipulated time, while the plant is yet to start commercial operations, company said. The observations are procedural in nature and will be responded to within the stipulated time, while the plant is yet to start commercial operations, company said.  Moneycontrol Latest News Read More  

प्रातिक्रिया दे

आपका ईमेल पता प्रकाशित नहीं किया जाएगा. आवश्यक फ़ील्ड चिह्नित हैं *

hi_INहिन्दी